Skip to main content
Clinical Trials/KCT0008703
KCT0008703
Recruiting
未知

Prospective observational study in patients who will undergo myectomy due to hypertrophic cardiomyopathy

Asan Medical Center0 sites100 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the circulatory system
Sponsor
Asan Medical Center
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who are 18 years of age or older and diagnosed with hypertrophic cardiomyopathy and scheduled to undergo myectomy at Asan Medical Center until January 1st, 2027 after IRB approval

Exclusion Criteria

  • Patients who are unable to provide informed consent for participation in the study or have diseases other than hypertrophic cardiomyopathy with a life expectancy of less than one year will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A prospective observational study for patients with community-acquired, health-care-associated, hospital-acquired, and ventilator-associated pneumonia in a Japanese University Hospitalcommunity-acquired (CAP), health-care-associated (HCAP), hospital-acquired (HAP), and ventilator-associated pneumonia (VAP)
JPRN-UMIN000007090Department of Respiratory Medicine, Nagoya University Graduate School of Medicine1,420
Recruiting
Not Applicable
A prospective observational study in patients with chronic liver disease by magnetic resonance elastographyChronic liver disease
JPRN-UMIN000045236Musashino Red Cross Hospital1,000
Completed
Not Applicable
A prospective observational study of patients with advanced cancer for the evaluation of checkpoint inhibitor-associated cardiovascular immune-related adverse eventsAdvanced non-small-cell lung cancer and advanced gastric cancer which are indications for anti-cytotoxic T-lymphocyte-associated antigen-4, anti-programmed death-1, and anti-programmed death-ligand 1 antibodies.
JPRN-UMIN000032729Frontline Immunotherapy Team, Sendai Kousei Hospital129
Recruiting
Not Applicable
A prospective observational study of patients with ankle sprain and instability in Korean Medicine clinics and hospital
KCT0004016Gachon University200
Not yet recruiting
Not Applicable
A Prospective Observational Study of patients who switched from SGLT2 inhibitor tablets to luseogliflozin OD film formulation in terms of feeling, Efficacy and Safety of taking the medicine.Type 2 Diabetes Mellitus
JPRN-UMIN000050476Seino internal Medicine Clinic60